litlas
Log inCreate account

Steve Vucic

Active 2003–2026

150
Papers
18,947
Citations
78
h-index
141
i10-index

Citations

Citations per year for Steve Vucic1951: 1 citations1977: 1 citations1985: 1 citations1986: 1 citations2003: 7 citations2005: 3 citations2006: 4 citations2007: 6 citations2008: 23 citations2009: 30 citations2010: 51 citations2011: 74 citations2012: 109 citations2013: 132 citations2014: 152 citations2015: 217 citations2016: 273 citations2017: 234 citations2018: 228 citations2019: 853 citations2020: 931 citations2021: 900 citations2022: 703 citations2023: 568 citations2024: 1,106 citations2025: 374 citations2026: 30 citations1952–1976: no citations, so these years are not shown1978–1984: no citations, so these years are not shown1987–2002: no citations, so these years are not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,585 citing papers, 17.6% of this breakdownUnited Kingdom: 819 citing papers, 9.1% of this breakdownItaly: 665 citing papers, 7.4% of this breakdownAustralia: 616 citing papers, 6.8% of this breakdownGermany: 614 citing papers, 6.8% of this breakdownChina: 471 citing papers, 5.2% of this breakdownCanada: 373 citing papers, 4.1% of this breakdownFrance: 343 citing papers, 3.8% of this breakdownSpain: 319 citing papers, 3.5% of this breakdownNetherlands: 265 citing papers, 2.9% of this breakdownSwitzerland: 215 citing papers, 2.4% of this breakdownJapan: 211 citing papers, 2.4% of this breakdown
0%17.6%Other 28%

Institutions

Fields

  • Medicine72.8%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Neuroscience9%
  • Immunology and Microbiology2.6%
  • Agricultural and Biological Sciences0.7%
  • Engineering0.6%
  • Other2.6%

Topics

  • Amyotrophic Lateral Sclerosis Research13.6%
  • Multiple Sclerosis Research Studies8.5%
  • Neurogenetic and Muscular Disorders Research7.2%
  • Peripheral Neuropathies and Disorders4.9%
  • Parkinson's Disease Mechanisms and Treatments3%
  • Alzheimer's disease research and treatments2.5%
  • Other60.3%

Coauthors

All papers

Open in search
  1. Amyotrophic lateral sclerosis

    Authors: Matthew C. Kiernan, Steve Vucic, Benjamin C. Cheah, Martin R. Turner, Andrew Eisen, Orla Hardiman, James R. Burrell, Margaret Zoing - The Lancet 2011 cited by 2,469

  2. TDP-43 proteinopathies: a new wave of neurodegenerative diseases

    Authors: Eva Maria Johanna de Boer, Viyanti K Orie, Timothy L. Williams, Mark R. Baker, Hugo M. De Oliveira, Tuomo Polvikoski, Matthew Silsby, Parvathi Menon, Mehdi van den Bos, Glenda M. Halliday, Leonard H. van den Berg, Ludo Van Den Bosch, Philip Van Damme, Matthew C. Kiernan, Michael A. van Es, Steve Vucic - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 377

  3. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee

    Authors: Steve Vucic, Kai‐Hsiang Chen, Matthew C. Kiernan, Mark Hallett, David Benninger, Vincenzo Di Lazzaro, Paolo Maria Rossini, Alberto Benussi, Alfredo Berardelli, Antonio Currà, Sandro M. Krieg, Jean‐Pascal Lefaucheur, Yew Long Lo, Richard Macdonell, Marcello Massimini, Mario Rosanova, Thomas Picht, Cathy M. Stinear, Walter Paulus, Yoshikazu Ugawa, Ulf Ziemann, Robert Chen - Clinical Neurophysiology 2023 cited by 202

  4. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Authors: Athena Hadjixenofontos, Ashley Beecham, Jacob L. McCauley, Clara P. Manrique, Margaret A Pericak‐Vance, Ioanna Konidari, Nikolaos A Patsopoulos, Philip L. De Jager, Michelle Lee, Irene Y. Frohlich, Nikolaos A. Patsopoulos, Chris Spencer, Gavin Band, Céline Bellenguez, Alexander T Dilthey, Céline Bellenguez, Colin Freeman, Alexander Dilthey, Dionysia K. Xifara, Gavin Band, Peter Donnelly, Chris C. A. Spencer, Loukas Moutsianas, Amy Strange, Matti Pirinen, Gil McVean, Mary F. Davis, Nathalie Schnetz‐Boutaud, Jonathan L. Haines, Alastair Compston, Barnaby Fiddes, Stephen Sawcer, Anu Kemppinen, Maria Ban, Amie Baker, Robert Andrews, Chris Cotsapas, Hannah Blackburn, Cristin McCabe, Chris Cotsapas, David A. Hafler, Chris Cotsapas, Carl A. Anderson, Jeffrey C. Barrett, Sarah Hunt, Sarah Edkins, Panos Deloukas, Tejas Shah, Hannah Blackburn, Cordelia Langford, Robert Andrews, David J. Booth, Steve Vucic, Graeme J. Stewart, Leentje Cosemans, An Goris, Bénédicte Dubois, Annette Oturai, Per Soelberg Sørensen, Helle Bach Søndergaard, Finn Sellebjerg, Janna Saarela, Virpi Leppä, Isabelle Cournu‐Rebeix, Bertrand Fontaine, Vincent Damotte, Angela Jochim, Juliane Winkelmann, Muni Hoshi, Achim Berthele, Thomas Korn, Rebecca Selter, Viola Biberacher, Volker Siffrin, Verena Grummel, Helena Kronsbein, Dorothea Buck, Laura Bergamaschi, Lucia Corrado, Filippo Martinelli-Boneschi, Claes Martin, Volker Siffrin, Frauke Zipp, Felix Luessi, Giuseppe Liberatore, Christiane Graetz, Eva Zindler, Mariaemma Rodegher, Lucia Corrado, Sandra D’Alfonso, Elisabeth G Celius, Inger-Lise Mero, Lucia Corrado, Sandra D’Alfonso, Jan Hillert, Tomas Olsson, Melissa Sorosina, Paola Brambilla, Giuseppe Liberatore, Magdalena Lindén and 93 more - Nature Genetics 2013 cited by 1,442

  5. Improving clinical trial outcomes in amyotrophic lateral sclerosis

    Authors: Matthew C. Kiernan, Steve Vucic, Kevin Talbot, Christopher McDermott, Orla Hardiman, Jeremy M. Shefner, Ammar Al‐Chalabi, William Huynh, Merit Cudkowicz, Paul Talman, Leonard H. van den Berg, Thanuja Dharmadasa, Paul Wicks, C.M. Reilly, Martin R. Turner - Nature Reviews Neurology 2020 cited by 291

  6. Defining secondary progressive multiple sclerosis

    Authors: Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Eva Havrdová, Dana Horáková, María Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, François Grand’Maison, Pierre Grammond, Raymond Hupperts, Raed Alroughani, Patrizia Sola, Cavit Boz, Eugenio Pucci, Jeannette Lechner‐Scott, Roberto Bergamaschi, Celia Oreja‐Guevara, Gerardo Iuliano, Vincent Van Pesch, Franco Granella, Cristina Ramo‐Tello, Daniele Spitaleri, Thor Petersen, Mark Slee, Freek Verheul, Radek Ampapa, Maria Pia Amato, Pamela McCombe, Steve Vucic, José Luis Sánchez-Menoyo, Edgardo Cristiano, Michael Barnett, Suzanne Hodgkinson, Javier Olascoaga, Maria Luisa Saladino, Orla Gray, Cameron Shaw, Fraser Moore, Helmut Butzkueven, Tomáš Kalinčík, on behalf of the MSBase Study Group - Brain 2016 cited by 416

  7. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

    Authors: Sudarshini Ramanathan, Shekeeb S. Mohammad, Esther Tantsis, Tina K. Nguyen, Vera Merheb, Victor S.C. Fung, Owen White, Simon Broadley, Jeannette Lechner‐Scott, Steve Vucic, Andrew Henderson, Michael Barnett, Stephen W Reddel, Fabienne Brilot, Russell C. Dale - Journal of Neurology Neurosurgery & Psychiatry 2017 cited by 561

  8. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis

    Authors: Steve Vucic, Garth A. Nicholson, Matthew C. Kiernan - Brain 2008 cited by 463

  9. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

    Authors: Sudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, Esther Tantsis, Stephen W Reddel, Andrew Henderson, Steve Vucic, Mark Gorman, Leslie Benson, Gülay Alper, Catherine J. Riney, Michael Barnett, John Parratt, Todd A. Hardy, Richard J. Leventer, Vera Merheb, Margherita Nosadini, Victor SC Fung, Fabienne Brilot, Russell C. Dale - Multiple Sclerosis Journal 2015 cited by 375

  10. Pathophysiological and diagnostic implications of cortical dysfunction in ALS

    Authors: Nimeshan Geevasinga, Parvathi Menon, P. Hande Özdi̇nler, Matthew C. Kiernan, Steve Vucic - Nature Reviews Neurology 2016 cited by 226

  11. Rate of disease progression: a prognostic biomarker in ALS

    Authors: Julie Labra, Parvathi Menon, Karen Byth, Shea Morrison, Steve Vucic - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 207

  12. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis

    Authors: Brian J. Wainger, Eric A. Macklin, Steve Vucic, Courtney McIlduff, Sabrina Paganoni, Nicholas J. Maragakis, Richard Bedlack, Namita Goyal, Seward B. Rutkove, Dale J. Lange, Michael H. Rivner, Stephen A. Goutman, Shafeeq Ladha, Elizabeth A. Mauricio, Robert H. Baloh, Zachary Simmons, Lindsay Pothier, Sylvia Baedorf Kassis, Thuong La, Meghan Hall, Armineuza Evora, David Klements, Aura Hurtado, João D. Pereira, Joan Koh, Pablo Celnik, Vinay Chaudhry, Karissa Gable, Vern C. Juel, Nicolás Phielipp, Adel Marei, Peter B. Rosenquist, Sean K. Meehan, Björn Oskarsson, Richard A. Lewis, Divpreet Kaur, Evangelos Kiskinis, Clifford J. Woolf, Kevin Eggan, Michael D. Weiss, James D. Berry, William S. David, Paula Davila-Pérez, Joan A. Camprodon, Álvaro Pascual‐Leone, Matthew C. Kiernan, Jeremy M. Shefner, Nazem Atassi, Merit Cudkowicz - JAMA Neurology 2020 cited by 139

  13. Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

    Authors: Andrew Hannaford, Nathan Pavey, Mehdi van den Bos, Nimeshan Geevasinga, Parvathi Menon, Jeremy M. Shefner, Matthew C. Kiernan, Steve Vucic - Annals of Neurology 2021 cited by 135

  14. Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial

    Authors: Julian Gold, Dominic B. Rowe, Matthew C. Kiernan, Steve Vucic, Susan Mathers, Ruben P. A. van Eijk, Avindra Nath, Marta García‐Montojo, Gina Norato, Ulisses A. Santamaria, Mary‐Louise Rogers, Andrea Malaspina, Vittoria Lombardi, Puja R. Mehta, Henk-Jan Westeneng, Leonard H. van den Berg, Ammar Al‐Chalabi - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019 cited by 101

  15. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study

    Authors: Parvathi Menon, Nimeshan Geevasinga, Con Yiannikas, James Howells, Matthew C. Kiernan, Steve Vucic - The Lancet Neurology 2015 cited by 209

  16. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis

    Authors: Rebecca K. Sheean, Fiona C. McKay, Erika Cretney, Christopher R. Bye, Nirma D. Perera, Doris Tomas, Richard A. Weston, Karlene J. Scheller, Elvan Djouma, Parvathi Menon, Stephen D. Schibeci, Najwa Marmash, Justin J. Yerbury, Stephen L. Nutt, David R. Booth, Graeme J. Stewart, Matthew C. Kiernan, Steve Vucic, Bradley J. Turner - JAMA Neurology 2018 cited by 171

  17. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques

    Authors: Mehdi van den Bos, Nimeshan Geevasinga, Mana Higashihara, Parvathi Menon, Steve Vucic - International Journal of Molecular Sciences 2019 cited by 144

  18. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS

    Authors: Parvathi Menon, Matthew C. Kiernan, Steve Vucic - Clinical Neurophysiology 2014 cited by 177

  19. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease

    Authors: Steve Vucic - Brain 2006 cited by 335

  20. Motor Neuron dysfunction in frontotemporal dementia

    Authors: James R. Burrell, Matthew C. Kiernan, Steve Vucic, John R. Hodges - Brain 2011 cited by 345

  21. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

    Authors: Tomáš Kalinčík, Vino Vivek, Vilija Jokubaitis, Jeannette Lechner‐Scott, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, François Grand’Maison, Raymond Hupperts, Celia Oreja‐Guevara, Roberto Bergamaschi, Gerardo Iuliano, Raed Alroughani, Vincent Van Pesch, Maria Pia Amato, Mark Slee, Freek Verheul, Ricardo Fernández‐Bolaños, Marcela Fiol, Daniele Spitaleri, Edgardo Cristiano, Orla Gray, José Antonio Cabrera-Gómez, Vahid Shaygannejad, Joseph Herbert, Steve Vucic, Merrilee Needham, Tatjana Petkovska‐Boskova, Carmen Adella Sîrbu, Pierre Duquette, Marc Girard, Pierre Grammond, Cavit Boz, Giorgio Giuliani, Maria Edite Rio, Michael Barnett, Shlomo Flechter, Fraser Moore, Bhim Singhal, Elizabeth Alejandra Bacile Bacile, Maria Luisa Saladino, Cameron Shaw, Eli Skromne, Dieter Poehlau, Norbert Vella, Timothy Spelman, Danny Liew, Trevor J. Kilpatrick, Helmut Butzkueven - Brain 2013 cited by 194

  22. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis

    Authors: Steve Vucic, Cindy Lin, Benjamin C. Cheah, Jenna Murray, Parvathi Menon, Arun V. Krishnan, Matthew C. Kiernan - Brain 2013 cited by 161

  23. Cortical hyperexcitability evolves with disease progression in ALS

    Authors: Parvathi Menon, Mana Higashihara, Mehdi van den Bos, Nimeshan Geevasinga, Matthew C. Kiernan, Steve Vucic - Annals of Clinical and Translational Neurology 2020 cited by 92

  24. Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension

    Authors: Steve Vucic, Parvathi Menon, William Huynh, Colin Mahoney, Karen S. Ho, Alan Hartford, Austin Rynders, Jacob Evan, Jeremy Evan, Shelia Ligozio, Robert Glanzman, Michael T. Hotchkin, Matthew C. Kiernan - EClinicalMedicine 2023 cited by 61